Concert Pharmaceuticals completes enrollment in second open label trial of CTP-543 in alopecia areata

Image: Concert Pharmaceuticals completes enrollment in second open label trial of CTP-543 in alopecia areata. Photo: courtesy of PublicDomainPictures from Pixabay.